These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29228678)

  • 61. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
    Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
    Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
    Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W
    Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
    Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
    Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
    Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
    J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long Noncoding RNA Small Nucleolar RNA Host Gene 3 Mediates Prostate Cancer Migration, Invasion, and Epithelial-Mesenchymal Transition by Sponging miR-487a-3p to Regulate
    Yu L; Ren Y
    Cancer Biother Radiopharm; 2022 Aug; 37(6):451-465. PubMed ID: 33416420
    [No Abstract]   [Full Text] [Related]  

  • 66. Ultrasound-mediated mesoporous silica nanoparticles loaded with PDLIM5 siRNA inhibit gefitinib resistance in NSCLC cells by attenuating EMT.
    Wu H; Lv WH; Zhu YY; Jia YY; Nie F
    Eur J Pharm Sci; 2023 Mar; 182():106372. PubMed ID: 36621614
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p-PIAS3-AKT2 signaling axis.
    Tseng JC; Huang SH; Lin CY; Wang BJ; Huang SF; Shen YY; Chuu CP
    Cell Death Dis; 2020 May; 11(5):376. PubMed ID: 32415173
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
    Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.
    Marampon F; Gravina G; Ju X; Vetuschi A; Sferra R; Casimiro M; Pompili S; Festuccia C; Colapietro A; Gaudio E; Di Cesare E; Tombolini V; Pestell RG
    Oncotarget; 2016 Feb; 7(5):5383-400. PubMed ID: 26689991
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
    Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
    BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Long noncoding RNA Linc00662 promotes the tumorigenesis of prostate cancer cells].
    Yao ZF; Pan ZY; Yao YW; Chen JF
    Zhonghua Nan Ke Xue; 2020 Jul; 26(7):588-594. PubMed ID: 33377712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway.
    Wang M; Huang W
    Biochem Pharmacol; 2023 Dec; 218():115893. PubMed ID: 37890593
    [TBL] [Abstract][Full Text] [Related]  

  • 73. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.
    Yi C; Wan X; Zhang Y; Fu F; Zhao C; Qin R; Wu H; Li Y; Huang Y
    Int J Biochem Cell Biol; 2018 Sep; 102():138-150. PubMed ID: 30053504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
    Pan MZ; Song YL; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
    Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
    Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway.
    Wu HE; Su CC; Wang SC; Liu PL; Cheng WC; Yeh HC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Chen YR; Yu YH; Huang SP; Li CY
    Am J Chin Med; 2023; 51(4):1019-1039. PubMed ID: 37120705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
    Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
    Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulation.
    Wang C; Che J; Jiang Y; Chen P; Bao G; Li C
    Cancer Biomark; 2022; 34(3):459-469. PubMed ID: 35253732
    [TBL] [Abstract][Full Text] [Related]  

  • 79. PDLIM5 links kidney anion exchanger 1 (kAE1) to ILK and is required for membrane targeting of kAE1.
    Su Y; Hiemstra TF; Yan Y; Li J; Karet HI; Rosen L; Moreno P; Karet Frankl FE
    Sci Rep; 2017 Jan; 7():39701. PubMed ID: 28045035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway.
    Zhou J; Peng S; Fan H; Li J; Li Z; Wang G; Zeng L; Guo Z; Lai Y; Huang H
    Cancer Med; 2023 Jun; 12(12):13471-13485. PubMed ID: 37119046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.